References
- Hashim F., Sakr F. M., Zeineldin E. In vitro release and in vivo absorption of nitrofurantoin and nalidixic acid from ethylcellulose microcapsules. Pharmazie 1987; 42: 315–317
- Hoener B., Pattenson S. E. Nitrofurantoin disposition. Clinical Pharmacology and Therapeutics 1981; 29: 808–816
- Kumar M., Singh J., Jayaswal S. B. Formulation and biopharmaceutical evaluation of sustained release tablets of nitrofurantoin. Indian Drugs 1982; 19: 140–142
- Martindale K. Nitrofurantoin and other urinary antimicrobial agents. Extra Pharmacopoeia, 28th edn. Pharmaceutical Press, London 1982; 1047–1049
- McGilveray I. J., Mattok G. L., Hossie R. D. A study of the bioavailabilities and dissolution rates of commercial tablets of nitrofurantoin. Journal of Pharmacy and Pharmacology 1971; 23
- Remington's Pharmaceutical Sciences. Mack, Pennsylvania 1985; 1215
- Turck M., Ronald A. R., Petersdorf R. G. Susceptibility of Entero-bacteriaceae to nitrofurantoin correlated with eradication of bacteriuria. Antimicrobial Agents Chemotherapy 1967; 1966: 446–452